NO990190L - Immunologisk fremgangsmÕte for pÕvisning av antistoffer rettet mot vevstransglutaminase (TTG), anvendelse av TTG for diagnostiske formÕl og terapikontroll og oralt farmas°ytisk middel inneholdende TTG - Google Patents

Immunologisk fremgangsmÕte for pÕvisning av antistoffer rettet mot vevstransglutaminase (TTG), anvendelse av TTG for diagnostiske formÕl og terapikontroll og oralt farmas°ytisk middel inneholdende TTG

Info

Publication number
NO990190L
NO990190L NO990190A NO990190A NO990190L NO 990190 L NO990190 L NO 990190L NO 990190 A NO990190 A NO 990190A NO 990190 A NO990190 A NO 990190A NO 990190 L NO990190 L NO 990190L
Authority
NO
Norway
Prior art keywords
ttg
therapy
detecting antibodies
diagnosis
diagnostic purposes
Prior art date
Application number
NO990190A
Other languages
English (en)
Other versions
NO990190D0 (no
NO321466B1 (no
Inventor
Tobias Ehnis
Detlef Schuppan
Walburga Dieterich
Original Assignee
Detlef Schuppan
Walburga Dieterich
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=7801172&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO990190(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Detlef Schuppan, Walburga Dieterich filed Critical Detlef Schuppan
Publication of NO990190D0 publication Critical patent/NO990190D0/no
Publication of NO990190L publication Critical patent/NO990190L/no
Publication of NO321466B1 publication Critical patent/NO321466B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/1025—Acyltransferases (2.3)
    • C12N9/104—Aminoacyltransferases (2.3.2)
    • C12N9/1044—Protein-glutamine gamma-glutamyltransferase (2.3.2.13), i.e. transglutaminase or factor XIII
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4713—Autoimmune diseases, e.g. Insulin-dependent diabetes mellitus, multiple sclerosis, rheumathoid arthritis, systemic lupus erythematosus; Autoantigens
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/573—Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Urology & Nephrology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cell Biology (AREA)
  • Rheumatology (AREA)
  • Pathology (AREA)
  • Wood Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Rehabilitation Therapy (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Diabetes (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
NO19990190A 1996-07-18 1999-01-15 Fremgangsmate for immunologisk pavisning av antistoffer rettet mot vevstransglutaminase (tTG), oralt farmasoytisk middel inneholdende tTG, samt anvendelse av tTG-inneholdende forbindelser. NO321466B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19630557A DE19630557C2 (de) 1996-07-18 1996-07-18 Verfahren zum Nachweis von Antikörpern aus Körperflüssigkeiten durch eine Immunreaktion mit Gewebe-Transglutaminase (tTG) sowie die Verwendung von tTG in Diagnose und Therapie
PCT/EP1997/003740 WO1998003872A2 (de) 1996-07-18 1997-07-14 IMMUNOLOGISCHES NACHWEISVERFAHREN VON ANTIKÖRPERN, DIE GEGEN GEWEBE-TRANSGLUTAMINASE (tTG) GERICHTET SIND, VERWENDUNG VON tTG ZUR DIAGNOSE UND THERAPIEKONTROLLE SOWIE ORALES PHARMAZEUTISCHES MITTEL ENTHALTEND tTG

Publications (3)

Publication Number Publication Date
NO990190D0 NO990190D0 (no) 1999-01-15
NO990190L true NO990190L (no) 1999-03-15
NO321466B1 NO321466B1 (no) 2006-05-15

Family

ID=7801172

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19990190A NO321466B1 (no) 1996-07-18 1999-01-15 Fremgangsmate for immunologisk pavisning av antistoffer rettet mot vevstransglutaminase (tTG), oralt farmasoytisk middel inneholdende tTG, samt anvendelse av tTG-inneholdende forbindelser.

Country Status (21)

Country Link
US (2) US6319726B1 (no)
EP (1) EP0912898B1 (no)
CN (1) CN1138146C (no)
AT (1) ATE210296T1 (no)
AU (1) AU718797B2 (no)
BR (1) BR9710500B1 (no)
CA (1) CA2260769C (no)
CZ (1) CZ291662B6 (no)
DE (2) DE19630557C2 (no)
DK (1) DK0912898T3 (no)
ES (1) ES2131038T3 (no)
GR (1) GR990300020T1 (no)
HU (1) HU228479B1 (no)
IL (1) IL128042A (no)
NO (1) NO321466B1 (no)
NZ (1) NZ333744A (no)
PL (1) PL189091B1 (no)
PT (1) PT912898E (no)
SI (1) SI9720044B (no)
SK (1) SK284410B6 (no)
WO (1) WO1998003872A2 (no)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1075267A2 (en) * 1998-05-06 2001-02-14 Kobenhavns Universitet Treatment of celiac disease
EP1200827B1 (en) * 1999-06-28 2004-06-16 Immundiagnostik AG Diagnosis of gluten sensitive enteropathy and other autoimmunopathies
US6703208B1 (en) 1999-10-20 2004-03-09 Immco Diagnostics Immunological assay for detection of antibodies in celiac disease
EP1222210A4 (en) * 1999-10-20 2004-12-08 Immco Diagnostics IMMUNOASSAY METHOD FOR THE DETECTION OF ANTIBODIES OF A CELIAC DISEASE
CU22968A1 (es) * 2000-06-07 2004-07-14 Ct Ingenieria Genetica Biotech Procedimiento para la detección de anticuerpos anti transglutaminasa con utilidad en el diagnóstico de la enfermedad celíaca
GB0103024D0 (en) * 2001-02-07 2001-03-21 Rsr Ltd Assay for Autoantibodies to tissue transglutaminase
FI20010868A0 (fi) * 2001-04-25 2001-04-25 Markku Maeki Menetelmä ja välineet gluteenin indusoimien tautien havaitsemiseksi
KR100488131B1 (ko) * 2001-07-07 2005-05-06 (주)푸드바이오테크 알레르기 진단용 단백질 칩과 알레르기 유발원의 검출방법 및 알레르기 유발 항체의 검출 방법
GB0117870D0 (en) * 2001-07-21 2001-09-12 Univ Nottingham Trent Method of diagnosis and kit of parts therefor
AU2003215272B2 (en) * 2002-02-14 2008-04-03 The Board Of Trustees Of The Leland Stanford Junior University Enzyme treatment of foodstuffs for celiac sprue
US8143210B2 (en) 2002-02-14 2012-03-27 The Board Of Trustees Of The Leland Stanford Junior University Enzyme treatment of foodstuffs for celiac sprue
US7320788B2 (en) * 2002-02-14 2008-01-22 The Board Of Trustees Of The Leland Stanford Junior University Enzyme treatment of foodstuffs for Celiac Sprue
RU2234086C2 (ru) * 2002-05-08 2004-08-10 Нижегородский научно-исследовательский институт детской гастроэнтерологии Способ дифференциальной диагностики целиакии и хронического энтерита у детей с патологией тонкой кишки
US7265093B2 (en) * 2002-05-14 2007-09-04 The Board Of Trustees Of The Leland Stanford Junior University Drug therapy for Celiac Sprue
US7605150B2 (en) * 2002-05-14 2009-10-20 The Board Of Trustees Of The Leland Stanford Junior University Drug therapy for Celiac Sprue
US7462688B2 (en) * 2002-05-14 2008-12-09 The Board Of Trustees Of The Leland Stanford Junior University Peptides for diagnostic and therapeutic methods for celiac sprue
US7202216B2 (en) * 2002-05-14 2007-04-10 The Board Of Trustees Of The Leland Stanford Junior University Drug therapy for celiac sprue
ATE554392T1 (de) 2002-11-20 2012-05-15 Univ Leland Stanford Junior Diagnoseverfahren für sprue/zöliakie
US7579313B2 (en) * 2003-11-18 2009-08-25 The Board Of Trustees Of The Leland Stanford Junior University Transglutaminase inhibitors and methods of use thereof
US7534426B2 (en) * 2004-04-26 2009-05-19 The Board Of Trustees Of The Leland Stanford Junior University Glutenase enzyme assays
US7563864B2 (en) * 2004-04-26 2009-07-21 Celiac Sprue Research Foundation Prolyl endopeptidase mediated destruction of T cell epitopes in whole gluten
US7628985B2 (en) * 2004-04-26 2009-12-08 The Board Of Regents Of The Leland Stanford Junior University Therapeutic enzyme formulations and uses thereof in celiac sprue and/or dermatitis herpetoformis
US20080038760A1 (en) * 2004-06-08 2008-02-14 Method For Decting Anti-Transglutaminase Antibodies Method for Detecting Anti-Transglutaminase Antibodies
WO2008012650A2 (en) 2006-07-25 2008-01-31 Augurix S.A. An immunochromatography device for the diagnosis of diseases in a sample
AU2008209176B2 (en) * 2007-01-26 2013-01-31 Ga Generic Assays Gmbh Method for assaying antibodies in body fluids by immune reaction with glycoprotein 2 (GP2) from zymogenic granules of the pancreas for the differential diagnosis of inflammatory intestinal diseases and chronic pancreatitis
EP2136833B1 (en) * 2007-03-16 2019-05-01 The Board of Trustees of the Leland Stanford Junior University Combination enzyme therapy for digestion of dietary gluten
EP1978364B1 (en) 2007-04-06 2011-06-01 Zedira GmbH Transglutaminase 6 as a diagnostic indicator of autoimmune diseases
HU0900199D0 (en) * 2009-04-01 2009-06-29 Debreceni Egyetem Diagnosis of gluten-induced autoimmune diseases
FR2949782B1 (fr) * 2009-09-04 2015-10-16 Isp Investments Inc Peptide activateur de la transglutaminase et composition cosmetique ou pharmaceutique le contenant.
WO2013119845A1 (en) 2012-02-07 2013-08-15 Vibrant Holdings, Llc Substrates, peptide arrays, and methods
DK2839290T3 (da) 2012-04-17 2019-06-11 Aeneas Gmbh & Co Kg Fremgangsmåde til præsymptomatisk diagnose af cøliaki og glutensensitivitet
DE102012007510A1 (de) 2012-04-17 2013-10-17 Aesku.Diagnostics GmbH & Co. KG Verfahren zur Präsymptomatischen Diagnostik von Zöliakie und Glutensensitivität
US10006909B2 (en) 2012-09-28 2018-06-26 Vibrant Holdings, Llc Methods, systems, and arrays for biomolecular analysis
US10286376B2 (en) 2012-11-14 2019-05-14 Vibrant Holdings, Llc Substrates, systems, and methods for array synthesis and biomolecular analysis
EP2956771B1 (en) 2013-02-15 2020-04-08 Vibrant Holdings, LLC Methods and compositions for amplified electrochemiluminescence detection
CN104090102B (zh) * 2014-06-13 2016-08-17 江南大学 冷冻鱼糜中微生物谷氨酰胺转胺酶elisa检测方法
EP3191629A4 (en) 2014-09-10 2018-07-11 Vibrant Holdings, LLC Peptide microarrays and novel biomarkers for celiac disease
WO2018218250A2 (en) 2017-05-26 2018-11-29 Vibrant Holdings, Llc Photoactive compounds and methods for biomolecule detection and sequencing
EP3790985B1 (en) 2018-05-09 2026-04-15 Vibrant Holdings, LLC Methods of synthesizing a polynucleotide array using photactivated agents
JP7664838B2 (ja) 2018-10-08 2025-04-18 ヴィブラント ホールディングス リミテッド ライアビリティ カンパニー セリアック病をモニタリングするためのｔＴＧ－ＤＧＰバイオマーカー
CN110055235A (zh) * 2019-05-14 2019-07-26 深圳市亚辉龙生物科技股份有限公司 用于转谷氨酰胺酶抗体检测的抗原及其制备方法、试剂盒及检测方法
WO2025233646A2 (en) 2024-05-09 2025-11-13 Debreceni Egyetem Detection of celiac disease-specific autoantibodies

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL155894B1 (en) * 1987-12-23 1992-01-31 Przed Zagraniczne W Polsce Pla Test for assessing gluten-dependent enteropathies
DE3829524A1 (de) * 1988-08-31 1990-03-01 Behringwerke Ag Verwendung von transglutaminasen als immunsuppressiva
DE19520480C2 (de) 1995-06-03 1997-04-30 Univ Leipzig Immunochemisches Testmaterial und Enzymimmunoassay zur Diagnostik von Zöliakie und verwandten Eiweißintoleranzen
US5716794A (en) * 1996-03-29 1998-02-10 Xybernaut Corporation Celiac antigen

Also Published As

Publication number Publication date
HK1021025A1 (en) 2000-05-26
DK0912898T3 (da) 2002-04-08
HUP0202779A2 (hu) 2002-12-28
CA2260769A1 (en) 1998-01-29
BR9710500B1 (pt) 2009-05-05
EP0912898A2 (de) 1999-05-06
NO990190D0 (no) 1999-01-15
BR9710500A (pt) 2000-01-18
IL128042A0 (en) 1999-11-30
SI9720044B (sl) 2003-02-28
SK284410B6 (sk) 2005-03-04
HUP0202779A3 (en) 2009-07-28
CN1225723A (zh) 1999-08-11
GR990300020T1 (en) 1999-06-30
CA2260769C (en) 2005-09-06
ES2131038T3 (es) 2002-09-01
CZ11799A3 (cs) 1999-07-14
EP0912898B1 (de) 2001-12-05
PT912898E (pt) 2002-05-31
CN1138146C (zh) 2004-02-11
HU228479B1 (en) 2013-03-28
SI9720044A (sl) 1999-08-31
DE19630557C2 (de) 1998-07-02
WO1998003872A2 (de) 1998-01-29
ES2131038T1 (es) 1999-07-16
PL189091B1 (pl) 2005-06-30
WO1998003872A3 (de) 1998-03-12
NZ333744A (en) 2000-03-27
PL331203A1 (en) 1999-07-05
US20020076834A1 (en) 2002-06-20
CZ291662B6 (cs) 2003-04-16
SK6799A3 (en) 2000-05-16
NO321466B1 (no) 2006-05-15
AU4201197A (en) 1998-02-10
IL128042A (en) 2007-06-17
US6319726B1 (en) 2001-11-20
DE19630557A1 (de) 1998-01-29
DE59705683D1 (de) 2002-01-17
ATE210296T1 (de) 2001-12-15
AU718797B2 (en) 2000-04-20

Similar Documents

Publication Publication Date Title
NO990190D0 (no) Immunologisk fremgangsmÕte for pÕvisning av antistoffer rettet mot vevstransglutaminase (TTG), anvendelse av TTG for diagnostiske formÕl og terapikontroll og oralt farmas°ytisk middel inneholdende TTG
DK0458079T3 (da) Ultralyd-kontrastmidler, fremgangsmåde til deres fremstilling og deres anvendelse som diagnostika og terapeutika
EP0909814A3 (en) Use of protein kinases for the diagnosis and treatment of Alzheimer's disease
DK480889D0 (da) Non-a, non-b, hepatitisvirus-antigenpeptid, cdna kodende derfor, fremgangsmaade til detektering deraf og bakteriestamme indeholdende et saadant cdna
MY105856A (en) Ultra sonic contrast agents, process for their preparation and their use as diagnostic and therapeutic agents.
GB9224584D0 (en) Use of outer membrane protein d15 and its peptides as vaccine against haempohilus influenzae diseases
EP0674661A4 (en) TITRATION AND TREATMENT FOR DEMYELINIZING DISEASES SUCH AS MULTIPLE SCLEROSIS.
FI912050A0 (fi) Menetelmä ihmisen papilloomaviruksen (HPV) toteamiseksi diagnostista käyttöä varten
AU2792789A (en) Method and means for selection of anti-idiotype antibodies and their use for the diagnosis, monitoring, treatment and/or prevention of cancer, autoimmune or infectious disease
DK172686A (da) Antigen opnaaet ud fra humant vaev, fremgangsmaade til under anvendelse af antigenet at fremstille monoklonale antistoffer til diagnose og behandling af cancer, fremgangsmaade til paavisning af cancer, samt antistoffer mod antigenet
FI933291A0 (fi) Foerfarande foer paovisning av anti-rna-antikroppar
AU2579995A (en) Alpha b crystallin for use in diagnosis and therapy of auto-immune diseases in particular multiple sclerosis
RU96121426A (ru) Способ диагностики опийной наркомании
HUP0102853A1 (hu) Moraxella catarrhalis-ból származó vegyületek
AU653332B2 (en) Synthetic peptides which contain sequences from factor VIIa, and the use thereof
RU95108454A (ru) Способ диагностики антифосфолипидного синдрома
CA2251058A1 (en) Diagnosis, prevention and treatment of ulcerative colitis, and clinical subtypes thereof, using histone h1
WO2001021653A3 (en) Ovarian tumor antigen and methods of use therefor
CA2151945A1 (en) Assay and treatment for demyelinating diseases such as multiple sclerosis
Douglas THE USE OF ART IN THE DIAGNOSIS AND TREATMENT OF BODY BOUNDARY DISTURBANCE IN SCHIZOPHRENIA.
Lavo Coeliac disease: Studies with gliadin challenge in a jejunal perfusion system.
FI953364A0 (fi) Kehon nesteistä tai kudoksista uutettujen synteettisten oligonukleotidien toteaminen
UA34279A (uk) Спосіб виявлення специфічного алергену
NO914755D0 (no) Peptider og derav deriverte motstoffer for diagnose av, terapi for og vaksinasjon mot htlv-1 infeksjon

Legal Events

Date Code Title Description
MK1K Patent expired